Trial to Evaluate the Efficacy and Safety of a Combination Therapy of Candesartan and Amlodipine Versus Candesartan Monotherapy in Hypertensive Patients Inadequately Controlled by Candesartan Monotherapy

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 135 participants.

Also called NCT02651870

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 135 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02651870
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02651870. Randomized; double masking; primary purpose treatment. Start 2015-04-22 (actual); primary completion 2016-02-25 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Trial to Evaluate the Efficacy and Safety of a Combination Therapy of Candesartan and Amlodipine Versus Candesartan Monotherapy in Hypertensive Patients Inadequately Controlled by Candesartan Monotherapy
Condition
Hypertension
Intervention (Drug)
Candesartan 16mg
Intervention (Drug)
Amlodipine 5mg
Intervention (Drug)
Amlodipine 10mg
Lead sponsor
Chong Kun Dang Pharmaceutical (class: industry)

Record details

Record id
cardio:ct-nct02651870
Content hash
bf33819d0516029733f2388c52fd3e621bb27aa8197f86a6f48d22af0e90aaa2